PEAK Stock Recent News
PEAK LATEST HEADLINES
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report third quarter 2023 financial results after the close of trading on the New York Stock Exchange on Monday, October 30, 2023. Healthpeak will host a conference call and webcast on Tuesday, October 31, 2023, at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) in order to review its financial performance and operati.
Well, you don't have to conjure up some investment that doesn't exist. Real estate investment trusts, often called REITs, are mandated to distribute profits to shareholders to maintain their special tax status.
With inflation across the United States proving to be more persistent than initially thought and the FED raising the cost of financing in myriad products from new homes to car loans, it is more important than ever for your money to really crank up the sweat factory.
The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
Healthpeak Properties, a healthcare REIT, is considered a potentially attractive investment due to its qualitative safety, good upside, and significantly above-average yield. The company's portfolio includes life science properties, outpatient medical care, and continuing care retirement communities, with a strong balance sheet and fundamentals, including a BBB+ rating and low net debt. Despite an unfavorable macro environment, Healthpeak had a strong start to 2023, with a focus on the life science and outpatient segment due to strong demand and fundamentals.
Healthpeak's (PEAK) Q2 earnings outshine estimates on higher revenues. Same-store portfolio cash (adjusted) net operating income improves year over year.
While the top- and bottom-line numbers for Healthpeak (PEAK) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Healthpeak (PEAK) came out with quarterly funds from operations (FFO) of $0.45 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to FFO of $0.44 per share a year ago.
Robust demand for Healthpeak's (PEAK) life-science assets combined with the improving operating trends of the CCRC portfolio is expected to have aided its Q2 earnings.
Healthpeak is one of the largest public healthcare REITs. Its 5.8% dividend yield is around two percentage points higher than that of its closest peers.